The Global Pulmonary Drugs Market Size Was Valued at USD 61.10 Billion in 2023 and is Projected to Reach USD 108.60 Billion by 2032, Growing at a CAGR of 6.60% From 2024-2032.
The Pulmonary Drugs market focuses on the development, clinical testing, and commercialization of pharmacological treatments designed to manage and treat diseases affecting the respiratory system. These medications...
English
Arabic
French
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek